Annals of Hepatology
Scope & Guideline
Innovating liver care with cutting-edge research.
Introduction
Aims and Scopes
- Hepatocellular Carcinoma Research:
The journal extensively covers research on hepatocellular carcinoma (HCC), focusing on prognostic factors, treatment efficacy, and novel therapeutic approaches, including immunotherapy and machine learning applications. - Metabolic Liver Diseases:
There is a significant emphasis on metabolic dysfunction-associated liver diseases, including non-alcoholic fatty liver disease (NAFLD) and its evolving nomenclature, reflecting a growing recognition of their clinical importance. - Viral Hepatitis Studies:
The journal publishes numerous articles on viral hepatitis, particularly hepatitis B and C, exploring topics from epidemiology to therapeutic advancements and the impact of these infections on liver health. - Transplantation and Surgical Interventions:
Research related to liver transplantation, including outcomes, complications, and innovative surgical techniques, is a core area, highlighting advancements in the management of end-stage liver disease. - Clinical and Epidemiological Insights:
The journal provides insights into the clinical aspects of liver diseases, including epidemiological studies that assess the burden of liver diseases in different populations, particularly in Latin America. - Emerging Therapeutic Approaches:
There is a focus on novel therapeutic strategies, including the use of biomarkers, liquid biopsies, and personalized medicine approaches to improve diagnosis and treatment outcomes in liver diseases.
Trending and Emerging
- Artificial Intelligence and Machine Learning in Hepatology:
There is an increasing trend towards integrating artificial intelligence and machine learning techniques to enhance diagnostic accuracy and predict patient outcomes in liver diseases. - Focus on Comorbidities and Multidisciplinary Approaches:
Research that explores the interplay between liver diseases and comorbidities, such as diabetes and cardiovascular diseases, is gaining traction, highlighting the need for a holistic approach to patient management. - Immunotherapy and Precision Medicine:
The application of immunotherapy in liver cancer treatment and the tailoring of therapies based on individual patient profiles are emerging as significant areas of interest in the journal. - Global Health Perspectives on Liver Diseases:
There is a growing emphasis on the epidemiological aspects of liver diseases in different regions, particularly in Latin America, reflecting the journal's commitment to addressing health disparities and public health challenges. - Patient-Centered Research and Quality of Life Studies:
A trend towards patient-centered research, focusing on the quality of life and psychosocial aspects of living with liver disease, is becoming more prominent, indicating a shift in research priorities.
Declining or Waning
- Traditional Alcohol-Related Liver Disease Research:
There has been a noticeable decline in papers specifically focused on traditional alcohol-related liver disease, as newer research trends emphasize metabolic liver diseases and their associated comorbidities. - Basic Science and Animal Models:
Studies relying heavily on basic science and animal models are becoming less frequent, with a shift towards clinical research and real-world evidence that informs practice directly. - Outdated Diagnostic Methods:
Research focused on older diagnostic methodologies, such as invasive liver biopsies, seems to be declining, with more emphasis on non-invasive techniques and biomarkers for liver disease assessment. - Hepatitis E Research:
While hepatitis E remains important, the number of studies specifically addressing this virus has decreased, possibly due to a growing focus on more prevalent viruses like hepatitis B and C.
Similar Journals
Korean Journal of Gastroenterology
Uniting Experts for Enhanced Digestive Health SolutionsKorean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.
HEPATOLOGY
Transforming liver health with groundbreaking insights.HEPATOLOGY is a premier scholarly journal dedicated to advancing the field of liver research and clinical practice. Published by Lippincott Williams & Wilkins, this journal boasts an impressive impact factor and holds a prestigious position as one of the top-ranked publications in both Hepatology (Q1) and Medicine (miscellaneous, Q1) categories as of 2023. HEPATOLOGY, with its commitment to disseminating high-quality research since its inception in 1981, serves as an essential platform for researchers, clinicians, and students focusing on liver diseases, including hepatitis, cirrhosis, and liver cancer. The journal's editorial board comprises leading experts who guide the publication towards its objective of fostering innovation and collaboration in this critical area of health. Although it does not offer an open access model, HEPATOLOGY ensures that its comprehensive analyses, reviews, and groundbreaking studies are accessible to the global medical community. Join the discourse in hepatology and be a part of a transformative journey through this indispensable resource.
HEPATOLOGY RESEARCH
Advancing liver health through groundbreaking research.Hepatology Research, ISSN 1386-6346 and E-ISSN 1872-034X, is a premier academic journal published by Wiley that serves the dynamic fields of Hepatology and Infectious Diseases. With an impressive 2023 impact factor and ranked Q2 in Hepatology and Q1 in Infectious Diseases, this journal stands out as a vital resource for researchers, professionals, and students. Covering a broad spectrum of topics related to liver health, the journal aims to disseminate cutting-edge research and insights from the converged years of 1997 to 2024. As an open-access platform, it fosters the global sharing of knowledge, providing valuable access to pioneering studies that address pressing issues in liver disease and its associated infections. Based in the United Kingdom, at 111 River St, Hoboken, NJ, Hepatology Research is pivotal for advancing scientific understanding and improving patient outcomes worldwide.
Translational Gastroenterology and Hepatology
Bridging Discovery and Care in Gastroenterology.Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Advancing knowledge in gastrointestinal and liver health.Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.
Saudi Journal of Gastroenterology
Exploring breakthroughs in gastrointestinal studies.The Saudi Journal of Gastroenterology is a premier platform dedicated to advancing research and clinical practice in the field of gastroenterology. Published by Wolters Kluwer Medknow Publications, this open-access journal has been serving the academic community since 1995 from its base in India. With an ISSN of 1319-3767 and an E-ISSN of 1998-4049, the journal allows unrestricted access to a wealth of knowledge, fostering an environment where researchers, professionals, and students can engage with cutting-edge studies. As of 2023, it is categorized in the Q3 quartile within gastroenterology, ranking #74 out of 167 in Scopus, which places it within the 55th percentile of its field. The journal aims to disseminate significant findings, clinical trials, and innovative theories that shape the understanding of gastrointestinal disorders and practices. With a commitment to quality and relevance, the Saudi Journal of Gastroenterology is pivotal for anyone seeking to enhance their knowledge and expertise in this vital area of medicine.
Hepatobiliary Surgery and Nutrition
Innovating hepatobiliary care for better patient outcomes.Hepatobiliary Surgery and Nutrition is a leading journal dedicated to advancing the fields of hepatobiliary surgery and nutritional science, published by AME Publishing Company. With a commitment to disseminate high-quality research, this journal serves as a vital platform for clinicians, researchers, and students alike to share their findings and insights related to liver and biliary health. The journal operates under an Open Access model, ensuring that cutting-edge research is readily available to a global audience. Although specific rankings and impact factors are currently not provided, the journal's focus on innovative surgical techniques and nutritional strategies underscores its importance in improving patient outcomes and shaping future practices in hepatobiliary medicine. Situated in Hong Kong, Hepatobiliary Surgery and Nutrition invites submissions that push the boundaries of knowledge in these crucial areas, fostering a collaborative environment for advancement in surgery and nutrition.
Hepatology Forum
Elevating hepatology insights for practitioners and scholars.Hepatology Forum is an esteemed journal dedicated to disseminating cutting-edge research and insights in the fields of gastroenterology and hepatology. Published by KARE PUBL in Turkey, this journal serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to advance their knowledge and practices related to liver diseases and gastrointestinal disorders. With an ISSN of 1307-5888 and an E-ISSN of 2757-7392, it features peer-reviewed articles that encompass a wide range of topics from basic research to clinical applications. Although categorized in the Q3 quartile for both gastroenterology and hepatology in 2023, Hepatology Forum continues to show significant potential for growth and impact, as evidenced by its Scopus rankings. Through its commitment to open scientific exchange, the journal not only facilitates the sharing of innovative methodologies and findings but also fosters networking among professionals in the field. As it converges through the years from 2020 to 2024, Hepatology Forum remains an important resource for the advancement of liver health and diseases, appealing to both established experts and emerging scholars alike.
JOURNAL OF HEPATOLOGY
Leading the Way in Hepatic Health DiscoveriesJOURNAL OF HEPATOLOGY, published by Elsevier, stands as a preeminent source in the field of Hepatology, with its impact underscored by a remarkable 2023 Category Quartile of Q1 and a Scopus rank of 3rd out of 82 journals, placing it in the 96th percentile for the discipline. Since its inception in 1985, this journal has been a vital conduit for the dissemination of pioneering research, clinical studies, and reviews related to liver diseases and their impact on global health. Although it currently does not offer open access options, the journal is committed to providing top-tier content to its readership—researchers, medical professionals, and students—in order to advance knowledge and foster innovation in hepatology. With a broad and inclusive scope, it aims to cover significant breakthroughs, therapeutic advancements, and epidemiological studies, continually pushing the boundaries of understanding in liver health. The journal is based in Amsterdam, Netherlands, and remains an essential resource for those dedicated to the progression of hepatologic science.
Clinical and Molecular Hepatology
Transforming the landscape of hepatology with cutting-edge studies.Clinical and Molecular Hepatology, published by the Korean Association for the Study of Liver, stands at the forefront of hepatology, offering a significant platform for research and innovation in liver diseases. Established in 1995 as an open access journal, it aims to disseminate high-quality research that spans the fields of hepatology, molecular biology, and medicine. With an impressive impact factor ranking it in the Q1 category for 2023 in both Hepatology and Molecular Biology, the journal facilitates a rich exchange of knowledge among professionals, researchers, and students globally. With its dedicated coverage from 2012 to 2024 and exceptional Scopus rankings placing it within the top 10% of journals in its field, Clinical and Molecular Hepatology is an indispensable resource for advancing the understanding and treatment of liver conditions. Located in Seoul, South Korea, the journal emphasizes rigorous peer review and is committed to enhancing clinical practice and molecular research, making it an ideal venue for groundbreaking studies in liver health.